When in medical school physician education is built on case studies - so it is not an exception that a physician presents a case study to a conference. It s still a scientific presentation.
CTSO was awarded the CE mark because the filter is safe and does what it s suppose to do, remove Cytokines.
Bertha was a long time poster on the SCLN MB well before Medasorb. Bertha's research here mirrors what was dione on the SCLN MB. I have, like most CtSO investors, more confidence in Bertha's post than in your misleading innuendos.
as Pearsby so eloquently (facetiously) quoted "..nearly 80% QoQ increase in a multi Billion market with no competitor's, numerous applications, 250 endorsing KOL's, 57 Studies, in UNMET diseases state(s)."
What should the market cap for this medical device be for a multi billion dollar market? A measly $1,000MM would equate to a pps of $33!
It is irritating that one says its "imminent" but on the other hand they are not to say when it happens.
Regardless, the CTSO continues to progress and the use of the filter advances.
The real frustration is seeing the decline in market cap. We are now under $200MM. The market for CBPS alone is $500MM to $1,000MM. So when we hear news about the partner and that relationship the PPS should get a nice pop - a PPS double from hear. Dr. Chan said the "evaluation is going well but is taking longer than expected."
The current weakness is at a good place to average down.
A week ago, I emailed Amy. V. and asked will there be a PR announcement when the EAP application is submitted. I was expecting a yes or no. I have not received a response. So I expect that the answer is no, and probably for your stated reason.
The worse thing that would happen is that the presentations would be relegated to CTSO's facebook/website as papers demonstrating the efficacy of the filter. I do hope that CTSO will put out a PR with longitudinal data from studies. That would have significant importance.
I agree that CTSO will continue to move up, how much is anyone's guess. At a pps of $10 the market cap will be around $300MM. When the cardiac partner is announce it will be interesting to hear what they may say regarding market size and potential - US and world. That should provide an impenitence for further price appreciation. I expect that to be in the range of $500MM to $1,500MM and I would expect the market cap to approach $500MM - a PPS of $18.
EAP designation would infer that the filter is a viable medical device with huge potential. I think the market cap could then double from there. If the momentum traders get involved with this stock of only 30MM shares who knows what might happen with the pps.
If it was that important you could research the company and see if they have a website with an email address or a phone number. Once you completed your research you could contact them. That way you won't frustrate yourself posting questions on a message board and not getting the answers you rightly so deserve.
Call Cytosorbents and get them to answer your questions - then comeback to the message board and share them.
If it such a concern why don't you ask that of Amy Vogel? Perhaps she can give you the broader feedback that would allay your anxiety.
Roberts is getting serious, who knows were the price of oil is going but hopefully it will stabilize. I would like to see the loonie get stronger. From the press release:
we will limit our capital expenditures to funds flow from operations by year-end 2015
we will suspend our dividend and reduce board compensation
we will significantly reduce our cost structure through a 35% workforce reduction
"We continue to take concrete steps to strengthen our balance sheet," said Dave Roberts, President and CEO of Penn West, "Limiting our capital programs to the funds flow generated from our assets and suspending our dividend are necessary steps. Building on a combination of process and efficiency improvements over the past 12 to 18 months, we are taking further actions today to significantly reduce our cost structure without impacting our ability to execute. We remain flexible and well positioned to move forward when oil prices improve."
I am not knowledgeable about how trading desks works, but I put in a small limit order and it was filled 100 shares at a time, it just took a while to complete.